rdf:type |
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0007634,
umls-concept:C0035648,
umls-concept:C0205195,
umls-concept:C0205464,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C0679199,
umls-concept:C1274040,
umls-concept:C1542147,
umls-concept:C2603343
|
pubmed:issue |
1
|
pubmed:dateCreated |
1996-9-12
|
pubmed:abstractText |
The objectives of the Cost Effectiveness of Lipid Lowering (CELL) study were twofold: (i) to evaluate the effect on overall cardiovascular risk of two types of health care advice ("usual' and "intensive') given in primary care, with or without pharmacological medication, with the target being to attain a moderate decrease in cholesterol; (ii) to evaluate the ritual of daily medication on compliance with the health care advice.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0954-6820
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
240
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13-22
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8708586-Adult,
pubmed-meshheading:8708586-Anticholesteremic Agents,
pubmed-meshheading:8708586-Cholesterol,
pubmed-meshheading:8708586-Coronary Disease,
pubmed-meshheading:8708586-Double-Blind Method,
pubmed-meshheading:8708586-Female,
pubmed-meshheading:8708586-Humans,
pubmed-meshheading:8708586-Life Style,
pubmed-meshheading:8708586-Male,
pubmed-meshheading:8708586-Middle Aged,
pubmed-meshheading:8708586-Patient Education as Topic,
pubmed-meshheading:8708586-Pravastatin,
pubmed-meshheading:8708586-Prospective Studies,
pubmed-meshheading:8708586-Risk Factors,
pubmed-meshheading:8708586-Time Factors,
pubmed-meshheading:8708586-Treatment Outcome
|
pubmed:year |
1996
|
pubmed:articleTitle |
Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study.
|
pubmed:affiliation |
Lund University, Department of Community Health Sciences, Sweden.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|